Feng Tian
43Patents
12h-index
80Co-inventors
80Inventor score
Filing activity: Jun 17, 2005 → Jan 11, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7632924B2 | Antigen-binding polypeptides and their uses | Chemistry; Metallurgy | 46 | Expired |
| US7919591B2 | Modified human plasma polypeptide or Fc scaffolds and their uses | Chemistry; Metallurgy | 38 | Active |
| US8053560B2 | Modified human plasma polypeptide or Fc scaffolds and their uses | Chemistry; Metallurgy | 35 | Active |
| US8618257B2 | Modified human plasma polypeptide or Fc scaffolds and their uses | Chemistry; Metallurgy | 31 | Active |
| US8420792B2 | Suppressor tRNA transcription in vertebrate cells | Chemistry; Metallurgy | 27 | Active |
| US7888533B2 | Accelerants for the modification of non-natural amino acids and non-natural amino acid polypeptides | Emerging Cross-Sectional Technologies | 25 | Active |
| US8278418B2 | Modified animal erythropoietin polypeptides and their uses | Chemistry; Metallurgy | 21 | Active |
| US8022186B2 | Modified human plasma polypeptide or Fc scaffolds and their uses | Chemistry; Metallurgy | 18 | Active |
| US8569233B2 | Modified animal erythropoietin polypeptides and their uses | Chemistry; Metallurgy | 17 | Active |
| US7632823B2 | Compositions of tRNA and uses thereof | Chemistry; Metallurgy | 16 | Active |
| US8071809B2 | Accelerants for the modification of non-natural amino acids and non-natural amino acid polypeptides | Emerging Cross-Sectional Technologies | 15 | Active |
| US7468458B2 | Accelerants for the modification of non-natural amino acids and non-natural amino acid polypeptides | Emerging Cross-Sectional Technologies | 13 | Active |
| US10227587B2 | Method for constructing a plasma DNA sequencing library | Chemistry; Metallurgy | 7 | Active |
| US9175083B2 | Antigen-binding polypeptides and their uses | Chemistry; Metallurgy | 6 | Active |
| US9121024B2 | Non-natural amino acid replication-dependent microorganisms and vaccines | Chemistry; Metallurgy | 4 | Active |
| US8940927B2 | Activators of glucokinase | Chemistry; Metallurgy | 4 | Active |
| US9488660B2 | Methods and compositions comprising non-natural amino acids | Physics | 3 | Active |
| US9121025B2 | Non-natural amino acid replication-dependent microorganisms and vaccines | Chemistry; Metallurgy | 2 | Active |
| US10800856B2 | Prostate-specific membrane antigen antibody drug conjugates | Chemistry; Metallurgy | 2 | Active |
| US9156899B2 | Modified animal erythropoietin polypeptides and their uses | Chemistry; Metallurgy | 2 | Active |
| US9644014B2 | Modified animal erythropoietin polypeptides and their uses | Chemistry; Metallurgy | 2 | Active |
| US8946148B2 | Modified insulin polypeptides and their uses | Human Necessities | 2 | Active |
| US9133495B2 | Hybrid suppressor tRNA for vertebrate cells | Chemistry; Metallurgy | 1 | Active |
| US10428333B2 | Non-natural amino acid replication-dependent microorganisms and vaccines | Chemistry; Metallurgy | 1 | Active |
| US10005805B2 | Activators of glucokinase | General | 0 | Revoked |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.